Treace Medical Concepts (TMCI) Net Margin Growth (3y) (2023 - 2026)

Treace Medical Concepts (TMCI) Net Margin Growth (3y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -388.00
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -1.00
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -315.00
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 1,692.00
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 2.00
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 1,018.00
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 399.00
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 Treace Medical Concepts 274.20 Mn 222.34 Mn 37.41 Mn -645.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -645.00
Dec 31, 2025 -192.00
Sep 30, 2025 409.00
Jun 30, 2025 2,054.00
Mar 31, 2025 57.00
Dec 31, 2024 1,889.00
Sep 30, 2024 -443.00
Jun 30, 2024 -2,316.00
Mar 31, 2024 -2,284.00
Dec 31, 2023 -2,023.00
Sep 30, 2023 -2,331.00
Jun 30, 2023 -193.00
Mar 31, 2023 -1,651.00